Florida’s Office of State Immunization and Disease Control (OSIDEC) is currently working on issuing two more vaccine licenses to Pfizer, Merck, and AstraZeneca.
As of Tuesday morning, the licenses were issued to Astra Zeneca, and Pfizer’s was approved by OSIDEC.
The state has until June 30 to issue a second license to Astarq, the world’s largest pharmaceutical company, to help supplement Florida’s existing vaccine coverage.
Florida is also working on obtaining three additional licenses to Astraflu, Boehringer Ingelheim, and Boehmermann for use in Florida.
All three companies are now awaiting approval for new licenses to begin issuing the vaccines.
At the same time, the Florida Department of Health has announced the completion of its first phase of an immunization program.
According to state health officials, the program will enroll more than 1,000 patients in its Vaccine Preparedness Initiative, a statewide initiative to increase access to vaccines and improve access to healthcare.
In addition, OSIDec has granted a provisional license to Merck for use to help ensure Florida can provide vaccines to patients as early as the beginning of next year.
Pfizer is now working on the third round of licensure for the Astra Zeiggen vaccine, which will help keep the company’s vaccine coverage going in Florida as it expands its presence in the state.
Earlier this week, the state of Texas announced that it was also working with Astra-Zeneca to make more vaccine-ready vaccines available in the Lone Star State.
OSIDec and Texas have not yet announced any further vaccine-related licenses.
AstraZeneca and Astraflue were the first two companies to license their vaccines to Florida.
The state’s current vaccine coverage is at 90 percent, and is expected to rise to 100 percent by 2020.
Follow all of our coverage of the federal government in this filed under Health,Healthcare,HealthCare News,Immunization News